TherapeuticsMD, Inc. SEC filings TXMD
TherapeuticsMD, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jun 23, 2008. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 11, 2026 | Aug 11, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2026 | May 2, 2026 |
| 10-K/A | Amended annual report | Apr 1, 2026 | Dec 31, 2025 |
| NT 10-K | Notification of late filing | Apr 1, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 30, 2026 | Mar 30, 2026 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Auditor change
|
Jan 21, 2026 | Jan 15, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Dec 16, 2025 | Dec 15, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2025 | Nov 12, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| ARS | Annual report to shareholders | Nov 3, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Nov 3, 2025 | — |
| DEF 14A | Proxy statement | Nov 3, 2025 | Dec 15, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 24, 2025 | Oct 24, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2025 | Aug 12, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 13, 2025 | May 13, 2025 |
| 10-K/A | Amended annual report | Apr 30, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Apr 9, 2025 | Apr 8, 2025 |
| 10-K | Annual report | Mar 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 27, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Dec 5, 2024 | Dec 5, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 12, 2024 | Nov 12, 2024 |
| ARS | Annual report to shareholders | Oct 25, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Oct 25, 2024 | — |
| DEF 14A | Proxy statement | Oct 25, 2024 | Dec 5, 2024 |
| 8-K | Current report | Sep 20, 2024 | Sep 20, 2024 |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2024 | Aug 12, 2024 |
| AW | Amendment withdrawal request | Jun 14, 2024 | — |
| 10-Q | Quarterly report | May 10, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 10, 2024 | May 10, 2024 |
| 10-K/A | Amended annual report | Apr 29, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 29, 2024 | Mar 29, 2024 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Aug 18, 2023 | Aug 15, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2023 | Aug 14, 2023 |
| D | Filing | Jul 11, 2023 | — |
| 8-K |
Current report
Auditor change
|
Jul 10, 2023 | Jul 7, 2023 |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change
|
Jul 6, 2023 | Jun 29, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 28, 2023 | Jun 26, 2023 |
| ARS | Annual report to shareholders | May 18, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | May 17, 2023 | — |
| DEF 14A | Proxy statement | May 17, 2023 | Jun 26, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Material agreement
|
May 5, 2023 | May 1, 2023 |
| PRE 14A | Preliminary proxy statement | May 1, 2023 | Jun 26, 2023 |
| 10-K/A | Amended annual report | May 1, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Other events
|
Apr 21, 2023 | Apr 21, 2023 |
| 10-K | Annual report | Apr 7, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 7, 2023 | Apr 7, 2023 |
| NT 10-K | Filing | Mar 31, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 27, 2023 | Feb 21, 2023 |
| 8-K |
Current report
Officer or director change
|
Jan 18, 2023 | Jan 11, 2023 |
| 8-K |
Current report
Listing notice
|
Jan 12, 2023 | Jan 6, 2023 |
| 8-K/A |
Amended current report
Officer or director change
|
Jan 6, 2023 | Dec 30, 2022 |
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Officer or director change, Regulation FD disclosure, Other events
|
Jan 3, 2023 | Dec 30, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 5, 2022 | Dec 4, 2022 |
| 8-K |
Current report
Material agreement
|
Dec 1, 2022 | Nov 30, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| D | Filing | Nov 14, 2022 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 31, 2022 | Oct 28, 2022 |
| D | Filing | Oct 17, 2022 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 3, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 12, 2022 | Sep 6, 2022 |
| 8-K |
Current report
Officer or director change
|
Aug 29, 2022 | Aug 23, 2022 |
| D | Filing | Aug 16, 2022 | — |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Aug 1, 2022 | Jul 29, 2022 |
| 8-K |
Current report
Material agreement
|
Jul 29, 2022 | Jul 28, 2022 |
| 8-K |
Current report
Material agreement
|
Jul 28, 2022 | Jul 27, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 25, 2022 | Jul 24, 2022 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Jul 14, 2022 | Jul 13, 2022 |
| SC 14D9/A | Filing | Jul 13, 2022 | — |
| SC TO-T/A | Filing | Jul 13, 2022 | — |
| SC 14D9/A | Filing | Jul 6, 2022 | — |
| SC TO-T/A | Filing | Jul 6, 2022 | — |
| SC 14D9/A | Filing | Jun 28, 2022 | — |
| SC TO-T/A | Filing | Jun 23, 2022 | — |
| SC 14D9 | Filing | Jun 13, 2022 | — |
| SC TO-T | Filing | Jun 6, 2022 | — |
| 8-K/A |
Amended current report
Bylaw or fiscal year change
|
Jun 6, 2022 | May 27, 2022 |
| 8-K |
Current report
Material agreement
|
Jun 3, 2022 | May 27, 2022 |
| SC TO-C | Filing | May 31, 2022 | — |
| SC14D9C | Filing | May 31, 2022 | — |
| 8-K |
Current report
Material agreement, Other events
|
May 31, 2022 | May 27, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 20, 2022 | May 20, 2022 |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
May 9, 2022 | May 3, 2022 |
| 10-K/A | Amended annual report | Apr 29, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Other events
|
Apr 27, 2022 | Apr 27, 2022 |
| 8-K |
Current report
Acquisition or sale of assets
|
Apr 20, 2022 | Apr 14, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 14, 2022 | Apr 14, 2022 |
| POS AM | Filing | Mar 24, 2022 | — |
| 10-K | Annual report | Mar 23, 2022 | Dec 31, 2021 |
| POSASR | Filing | Mar 23, 2022 | — |
| 8-K |
Current report
Listing notice, Officer or director change
|
Mar 18, 2022 | Mar 14, 2022 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure
|
Mar 10, 2022 | Mar 6, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 7, 2022 | Mar 7, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 18, 2022 | Feb 17, 2022 |
| 8-K |
Current report
Other events
|
Jan 3, 2022 | Dec 28, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 20, 2021 | Dec 14, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 17, 2021 | Dec 13, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 10, 2021 | Dec 10, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 8, 2021 | Dec 7, 2021 |
| 8-K/A |
Amended current report
Results of operations, Regulation FD disclosure
|
Nov 16, 2021 | Nov 11, 2021 |
| 10-Q | Quarterly report | Nov 12, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Nov 12, 2021 | Nov 11, 2021 |
| S-8 | Employee stock plan registration | Oct 15, 2021 | — |
| SC TO-I/A | Filing | Oct 1, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Oct 1, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Listing notice
|
Sep 17, 2021 | Sep 15, 2021 |
| 8-K |
Current report
Other events
|
Sep 7, 2021 | Sep 2, 2021 |
| S-8 | Employee stock plan registration | Aug 31, 2021 | — |
| SC TO-I/A | Filing | Aug 30, 2021 | — |
| SC TO-I | Filing | Aug 26, 2021 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 9, 2021 | Aug 3, 2021 |
| 10-Q | Quarterly report | Aug 4, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 4, 2021 | Aug 4, 2021 |
| S-8 | Employee stock plan registration | Jun 8, 2021 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 28, 2021 | May 27, 2021 |
| DEFA14A | Additional proxy material | May 21, 2021 | — |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2021 | May 6, 2021 |
| SEC STAFF LETTER | Filing | Apr 19, 2021 | — |
| DEFA14A | Additional proxy material | Apr 14, 2021 | — |
| DEF 14A | Proxy statement | Apr 14, 2021 | May 27, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 12, 2021 | Apr 8, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 1, 2021 | May 27, 2021 |
| SEC STAFF LETTER | Filing | Mar 22, 2021 | — |
| S-3ASR | Automatic shelf registration | Mar 4, 2021 | — |
| 10-K | Annual report | Mar 4, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 2, 2021 | Mar 2, 2021 |
| 8-K |
Current report
Material agreement
|
Feb 16, 2021 | Feb 11, 2021 |
| 424B2 | Prospectus | Feb 16, 2021 | — |
| 424B5 | Prospectus supplement | Feb 10, 2021 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 13, 2021 | Jan 13, 2021 |
| 424B5 | Prospectus supplement | Nov 27, 2020 | — |
| 8-K |
Current report
Material agreement, Officer or director change
|
Nov 27, 2020 | Nov 24, 2020 |
| 8-K |
Current report
Material agreement
|
Nov 13, 2020 | Nov 10, 2020 |
| 424B2 | Prospectus | Nov 12, 2020 | — |
| 424B5 | Prospectus supplement | Nov 9, 2020 | — |
| 10-Q | Quarterly report | Nov 9, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 9, 2020 | Nov 9, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 14, 2020 | Sep 14, 2020 |
| D | Filing | Aug 14, 2020 | — |
| S-8 | Employee stock plan registration | Aug 7, 2020 | — |
| 10-Q | Quarterly report | Aug 7, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2020 | Aug 6, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 23, 2020 | Jun 23, 2020 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 18, 2020 | Jun 18, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 1, 2020 | Jun 1, 2020 |
| 8-K |
Current report
Agreement ended, Other events
|
May 15, 2020 | May 14, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
May 13, 2020 | May 13, 2020 |
| 10-Q | Quarterly report | May 6, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2020 | May 6, 2020 |
| EFFECT | Filing | May 5, 2020 | — |
| DEFA14A | Additional proxy material | May 4, 2020 | — |
| DEF 14A | Proxy statement | May 4, 2020 | Jun 18, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
May 1, 2020 | Apr 27, 2020 |
| 10-K/A | Amended annual report | Apr 29, 2020 | Dec 31, 2019 |
| PRER14A | Preliminary revised proxy soliciting materials | Apr 22, 2020 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Apr 22, 2020 | Apr 16, 2020 |
| PRE 14A | Preliminary proxy statement | Apr 13, 2020 | Jun 18, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 26, 2020 | Mar 26, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 24, 2020 | Mar 20, 2020 |
| SEC STAFF LETTER | Filing | Mar 5, 2020 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 3, 2020 | Mar 3, 2020 |
| POS AM | Filing | Feb 24, 2020 | — |
| 10-K | Annual report | Feb 24, 2020 | Dec 31, 2019 |
| POSASR | Filing | Feb 24, 2020 | — |
| 8-K |
Current report
Results of operations, New debt, Regulation FD disclosure
|
Feb 20, 2020 | Feb 18, 2020 |
| SEC STAFF LETTER | Filing | Feb 4, 2020 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 14, 2020 | Jan 14, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 30, 2019 | Dec 27, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 18, 2019 | Dec 18, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 19, 2019 | Nov 19, 2019 |
| 10-Q | Quarterly report | Nov 8, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 6, 2019 | Nov 6, 2019 |
| 8-K |
Current report
Material agreement
|
Oct 29, 2019 | Oct 24, 2019 |
| 424B2 | Prospectus | Oct 25, 2019 | — |
| FWP | Free writing prospectus | Oct 24, 2019 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 23, 2019 | Oct 23, 2019 |
| FWP | Free writing prospectus | Oct 23, 2019 | — |
| 424B5 | Prospectus supplement | Oct 23, 2019 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 15, 2019 | Oct 15, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 1, 2019 | Oct 1, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 25, 2019 | Sep 25, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 16, 2019 | Sep 16, 2019 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TXMD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Boca Raton, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 25743
- Former names
- AMHN, Inc. (until Sep 14, 2011); CROFF ENTERPRISES INC (until Sep 4, 2009); CROFF OIL CO (until Apr 1, 1997)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.